Literature DB >> 15541311

GFRalpha1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration.

Hideki Enomoto1, Inna Hughes, Judith Golden, Robert H Baloh, Shigenobu Yonemura, Robert O Heuckeroth, Eugene M Johnson, Jeffrey Milbrandt.   

Abstract

The GDNF family ligands signal through a receptor complex composed of a ligand binding subunit, GFRalpha, and a signaling subunit, the RET tyrosine kinase. GFRalphas are expressed not only in RET-expressing cells, but also in cells lacking RET. A body of evidence suggests that RET-independent GFRalphas are important for (1) modulation of RET signaling in a non-cell-autonomous fashion (trans-signaling) and (2) regulation of NCAM function. To address the physiological significance of these roles, we generated mice specifically lacking RET-independent GFRalpha1. These mice exhibited no deficits in regions where trans-signaling has been implicated in vitro, including enteric neurons, motor neurons, kidney, and regenerating nerves. Furthermore, no abnormalities were found in the olfactory bulb, which requires proper NCAM function for its formation and is putatively a site of GDNF-GFRalpha-NCAM signaling. Thus RET-independent GFRalpha1 is dispensable for organogenesis and nerve regeneration in vivo, indicating that trans-signaling and GFRalpha-dependent NCAM signaling play a minor role physiologically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541311     DOI: 10.1016/j.neuron.2004.10.032

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  28 in total

1.  The many faces of RET dysfunction in kidney.

Authors:  Sanjay Jain
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

2.  Wnt7A identifies embryonic γ-motor neurons and reveals early postnatal dependence of γ-motor neurons on a muscle spindle-derived signal.

Authors:  Soha Ashrafi; Melanie Lalancette-Hébert; Andreas Friese; Markus Sigrist; Silvia Arber; Neil A Shneider; Julia A Kaltschmidt
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

Review 3.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

Review 4.  Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung's disease.

Authors:  G Burzynski; I T Shepherd; H Enomoto
Journal:  Neurogastroenterol Motil       Date:  2009-02       Impact factor: 3.598

5.  A protein tyrosine kinase receptor, c-RET signaling pathway contributes to the enteric neurogenesis induced by a 5-HT4 receptor agonist at an anastomosis after transection of the gut in rodents.

Authors:  Kei Goto; Isao Kawahara; Hiroki Kuniyasu; Miyako Takaki
Journal:  J Physiol Sci       Date:  2015-04-08       Impact factor: 2.781

Review 6.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

7.  Stage specific requirement of Gfrα1 in the ureteric epithelium during kidney development.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Mech Dev       Date:  2013-03-28       Impact factor: 1.882

8.  Dynamic expression of neurotrophic factor receptors in postnatal spinal motoneurons and in mouse model of ALS.

Authors:  Jiasheng Zhang; Eric J Huang
Journal:  J Neurobiol       Date:  2006-07

9.  Regionalized loss of parvalbumin interneurons in the cerebral cortex of mice with deficits in GFRalpha1 signaling.

Authors:  Alison J Canty; Jule Dietze; Michael Harvey; Hideki Enomoto; Jeffrey Milbrandt; Carlos F Ibáñez
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

10.  Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival.

Authors:  Neil A Shneider; Meghan N Brown; Courtney A Smith; James Pickel; Francisco J Alvarez
Journal:  Neural Dev       Date:  2009-12-02       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.